title: Quantitative Systems Pharmacology Model of NO Metabolome and Methemoglobin Following Long-Term Infusion of Sodium Nitrite in Humans.
abstract: A long-term sodium nitrite infusion is intended for the treatment of vascular disorders. Phase I data demonstrated a significant nonlinear dose-exposure-toxicity relationship within the therapeutic dosage range. This study aims to develop a quantitative systems pharmacology model characterizing nitric oxide (NO) metabolome and methemoglobin after sodium nitrite infusion. Nitrite, nitrate, and methemoglobin concentration-time profiles in plasma and RBC were used for model development. Following intravenous sodium nitrite administration, nitrite undergoes conversion in RBC and tissue. Nitrite sequestered by RBC interacts more extensively with deoxyhemoglobin, which contributes greatly to methemoglobin formation. Methemoglobin is formed less-than-proportionally at higher nitrite doses as characterized with facilitated methemoglobin removal. Nitrate-to-nitrite reduction occurs in tissue and via entero-salivary recirculation. The less-than-proportional increase in nitrite and nitrate exposure at higher nitrite doses is modeled with a dose-dependent increase in clearance. The model provides direct insight into NO metabolome disposition and is valuable for nitrite dosing selection in clinical trials.CPT: Pharmacometrics & Systems Pharmacology (2013) 2, e60; doi:10.1038/psp.2013.35; published online 31 July 2013.
authors.affiliation: Department of Pharmaceutical Sciences, College of Pharmacy, the University of Oklahoma Health Sciences Center, Oklahoma, USA.
authors.forename: K
authors.initials: K
authors.lastname: Vega-Villa
authors.forename: R
authors.initials: R
authors.lastname: Pluta
authors.forename: R
authors.initials: R
authors.lastname: Lonser
authors.forename: S
authors.initials: S
authors.lastname: Woo
references.citation: Acc Chem Res. 2009 Jan 20;42(1):157-67
references.pmid: 18783254
references.citation: Nat Rev Drug Discov. 2008 Feb;7(2):156-67
references.pmid: 18167491
references.citation: Blood. 2005 Jul 15;106(2):734-9
references.pmid: 15774613
references.citation: Mini Rev Med Chem. 2005 Mar;5(3):247-54
references.pmid: 15777259
references.citation: J Biol Chem. 2007 Apr 27;282(17):12916-27
references.pmid: 17322300
references.citation: Blood Rev. 2005 Mar;19(2):61-8
references.pmid: 15603910
references.citation: Clin Sci (Lond). 2000 May;98(5):507-20
references.pmid: 10781381
references.citation: Drug Metab Dispos. 2010 Oct;38(10):1707-13
references.pmid: 20634335
references.citation: J Clin Invest. 2004 Jan;113(1):106-14
references.pmid: 14702114
references.citation: Circulation. 2007 Oct 16;116(16):1821-31
references.pmid: 17893272
references.citation: Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2565-72
references.pmid: 17766472
references.citation: Nat Chem Biol. 2006 Sep;2(9):486-93
references.pmid: 16906150
references.citation: Drug Metab Dispos. 2002 Jun;30(6):676-83
references.pmid: 12019195
references.citation: Am J Physiol. 1998 Jul;275(1):F68-73
references.pmid: 9689006
references.citation: Brain. 2008 Mar;131(Pt 3):760-1
references.pmid: 18202104
references.citation: Free Radic Biol Med. 2009 Apr 15;46(8):1068-75
references.pmid: 19439233
references.citation: Cancer Res. 1983 Apr;43(4):1921-5
references.pmid: 6831427
references.citation: Nitric Oxide. 2012 May 15;26(4):229-40
references.pmid: 22491087
references.citation: Clin Pharmacol Ther. 2013 May;93(5):379-81
references.pmid: 23598453
references.citation: Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1398-407
references.pmid: 19286940
references.citation: Mt Sinai J Med. 2012 Jan-Feb;79(1):66-74
references.pmid: 22238040
references.citation: Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7674-7
references.pmid: 1502182
references.citation: Free Radic Biol Med. 2011 Aug 15;51(4):805-12
references.pmid: 21683783
references.citation: PLoS One. 2011 Jan 10;6(1):e14504
references.pmid: 21249218
references.citation: Circ Res. 2007 Mar 16;100(5):654-61
references.pmid: 17293481
references.citation: Proc Natl Acad Sci U S A. 1981 Dec;78(12):7764-8
references.pmid: 6950416
references.citation: J Pharmacokinet Biopharm. 1993 Aug;21(4):457-78
references.pmid: 8133465
references.citation: J Pharmacokinet Biopharm. 1996 Dec;24(6):611-35
references.pmid: 9300353
references.citation: Cardiovasc Res. 2011 Feb 15;89(3):492-8
references.pmid: 20884639
references.citation: Nitric Oxide. 2008 Dec;19(4):333-7
references.pmid: 18793740
references.citation: Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H499-508
references.pmid: 18539756
references.citation: Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2026-35
references.pmid: 16798825
references.citation: J Biol Chem. 2005 Nov 25;280(47):39024-32
references.pmid: 16186121
references.citation: Biochem J. 2009 Sep 25;423(2):169-77
references.pmid: 19650765
references.citation: AAPS J. 2011 Jun;13(2):143-51
references.pmid: 21302010
references.citation: Curr Clin Pharmacol. 2009 May;4(2):132-41
references.pmid: 19442078
references.citation: N Engl J Med. 2006 Dec 28;355(26):2792-3
references.pmid: 17192551
references.citation: J Inorg Biochem. 2005 Jan;99(1):247-66
references.pmid: 15598505
references.citation: Blood. 2008 Oct 1;112(7):2636-47
references.pmid: 18596228
references.citation: Am J Physiol Regul Integr Comp Physiol. 2010 Apr;298(4):R972-82
references.pmid: 20130222
references.citation: Free Radic Biol Med. 2004 Aug 1;37(3):395-400
references.pmid: 15223073
references.citation: Nat Chem Biol. 2008 Jul;4(7):411-7
references.pmid: 18516050
references.citation: J Pharmacokinet Pharmacodyn. 2006 Apr;33(2):167-93
references.pmid: 16547797
references.citation: Nat Med. 2003 May;9(5):496-500
references.pmid: 12724752
references.citation: Nat Chem Biol. 2007 Dec;3(12):785-94
references.pmid: 17982448
references.citation: Clin Chim Acta. 2003 Apr;330(1-2):85-98
references.pmid: 12636927